Sound Income Strategies LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,069 shares of the healthcare conglomerate’s stock after purchasing an additional 129 shares during the period. Sound Income Strategies LLC’s holdings in UnitedHealth Group were worth $1,047,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. M&T Bank Corp raised its stake in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after buying an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC lifted its holdings in UnitedHealth Group by 17.6% during the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. increased its stake in shares of UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares in the last quarter. Parsifal Capital Management LP purchased a new position in UnitedHealth Group in the 3rd quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC increased its stake in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after buying an additional 1,051 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts recently commented on UNH shares. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft raised their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $627.74.
UnitedHealth Group Price Performance
UNH stock opened at $532.26 on Friday. The business’s fifty day moving average price is $542.24 and its 200 day moving average price is $563.54. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $489.83 billion, a PE ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm posted $5.83 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.74 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.58%. UnitedHealth Group’s payout ratio is 54.19%.
Insider Buying and Selling at UnitedHealth Group
In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What Investors Need to Know to Beat the Market
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Trading Stocks: RSI and Why it’s Useful
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is Put Option Volume?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.